Beckley Psytech fetches $80m Series B
Beckley Psytech, a UK-based developer of psychedelic medicines, has raised $80 million in Series B financing.
Beckley Psytech, a UK-based developer of psychedelic medicines, has raised $80 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination
